The peroxisome proliferator-activated receptor gamma agonist rosiglitazone inhibits growth and downregulates Bcl-2 gene expression in human follicular thyroid cancer cells
Year: 2004
Type: conference-abstract
Source: Annals of Surgical Oncology
DOI: 10.1007/bf02524134
Institution: University of California, San Francisco
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2040106411
